TALAROMYCOSIS

Clinical trials for TALAROMYCOSIS explained in plain language.

Never miss a new study

Get alerted when new TALAROMYCOSIS trials appear

Sign up with your email to follow new studies for TALAROMYCOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 2 Completed 1

New hope against deadly mold infections: generic drug shows promise

Disease control Completed

This study tested a generic version of an antifungal drug called Amphotericin B Cholesteryl Sulfate Complex (ABCD) in 67 adults with invasive mold disease, a serious infection. The goal was to see if the drug is safe and works well. Participants received the drug through an IV, a…

Matched conditions: TALAROMYCOSIS

Phase: PHASE3 • Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 07:59 UTC

TALAROMYCOSIS

Get alerted when new TALAROMYCOSIS trials appear

New hope against deadly mold infections: generic drug shows promise